P. Crasta

发表

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis

O. Van Der Meeren, B. Cheuvart, P. Crasta, 2015, Human vaccines & immunotherapeutics.

Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response

A. Theamboonlers, Y. Poovorawan, V. Chongsrisawat, 2013, Human vaccines & immunotherapeutics.

Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine

P. van Damme, K. Van Herck, P. Crasta, 2012, Human vaccines & immunotherapeutics.

Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.

M. Avdičová, Martina Kovac, P. Crasta, 2015, Vaccine.

A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults

O. Van Der Meeren, P. Crasta, M. de Ridder, 2015, Human vaccines & immunotherapeutics.

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers

G. Leroux-Roels, A. Theamboonlers, Y. Poovorawan, 2012, Human vaccines & immunotherapeutics.

Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.

O. Van Der Meeren, P. Crasta, U. Behre, 2016, Vaccine.

Clarification to Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vaccin Immunother 2012; 8:813-8

P. Crasta, U. Behre, M. Messier, 2012, Human vaccines & immunotherapeutics.

Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.

N. Hens, P. van Damme, H. Theeten, 2015, Vaccine.

Antibody persistence and immune memory in adults, 15 years after a three‐dose schedule of a combined hepatitis A and B vaccine

P. van Damme, G. Leroux-Roels, K. Van Herck, 2012, Journal of medical virology.

Immune memory to hepatitis B persists in children aged 7–8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine

O. Van Der Meeren, P. Crasta, Gerhard Bleckmann, 2014, Human vaccines & immunotherapeutics.

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

P. Ebeling, M. Dionne, R. Simpson, 2016, Human vaccines & immunotherapeutics.

Lasting immune memory against hepatitis B in 12–13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

N. Mesaros, O. Van Der Meeren, P. Crasta, 2016, Human vaccines & immunotherapeutics.

Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.

N. Hens, P. van Damme, H. Theeten, 2015, Vaccine.

Anti-HBs antibody persistence following primary vaccination with an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency

M. Jadoul, P. Peeters, S. Houard, 2011, Human vaccines.